These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Transfusion of blood and products derived from blood]. Wautier JL Rev Prat; 1999 Feb; 49(4):409-13. PubMed ID: 10319693 [No Abstract] [Full Text] [Related]
4. Limitations of component therapy for massive haemorrhage: is whole blood the whole solution? Hall S; Murphy MF Anaesthesia; 2015 May; 70(5):511-4. PubMed ID: 25866037 [No Abstract] [Full Text] [Related]
5. Blood transfusion: old blood, new blood or no blood. Duggan JM Intern Med J; 2011 Apr; 41(4):358-9. PubMed ID: 21507166 [TBL] [Abstract][Full Text] [Related]
7. [Immunological aspects of blood transfusion preparations]. Matinlauri I Duodecim; 2004; 120(7):867-75. PubMed ID: 15154308 [No Abstract] [Full Text] [Related]
8. [Blood and plasma transfusion in the treatment of acute blood loss]. Hiippala S Duodecim; 2004; 120(7):893-901. PubMed ID: 15154311 [No Abstract] [Full Text] [Related]
9. Blood transfusion: less is more? Carson JL; Armas-Loughran B Crit Care Med; 2003 Sep; 31(9):2409-10. PubMed ID: 14501980 [No Abstract] [Full Text] [Related]
10. The transfusion dilemma--weighing the known and newly proposed risks of blood transfusions against the uncertain benefits. Refaai MA; Blumberg N Best Pract Res Clin Anaesthesiol; 2013 Mar; 27(1):17-35. PubMed ID: 23590913 [TBL] [Abstract][Full Text] [Related]
11. Blood transfusion: a practical guide. Burdett E; Stephens R Br J Hosp Med (Lond); 2006 Apr; 67(4):M67-9. PubMed ID: 16681309 [No Abstract] [Full Text] [Related]
13. [Results of a consensus conference on the topic, "Homologous blood saving methods in surgical medicine"]. Chirurg; 1992 Jul; 63(7):suppl 110-7. PubMed ID: 1505253 [No Abstract] [Full Text] [Related]
14. [Blood transfusion and blood product risks and alternatives (from the civil law viewpoint of the judge)]. Schlund GH Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):M133-6. PubMed ID: 8001747 [No Abstract] [Full Text] [Related]
15. [Transfusion of blood and blood derivatives. Measurements of safety, circulatory, immunologic and infectious risks and accidents]. Rouger P; Hergon E Rev Prat; 1997 Sep; 47(13):1499-504. PubMed ID: 9339033 [No Abstract] [Full Text] [Related]
16. Why an alternative to blood transfusion? Shander A; Goodnough LT Crit Care Clin; 2009 Apr; 25(2):261-77, Table of Contents. PubMed ID: 19341908 [TBL] [Abstract][Full Text] [Related]
17. Hemoglobin-based blood substitutes and risk of myocardial infarction and death. Sauaia A; Moore EE; Banerjee A JAMA; 2008 Sep; 300(11):1297; author reply 1298-9. PubMed ID: 18799440 [No Abstract] [Full Text] [Related]
18. The risks associated with blood and blood product transfusion. Higgins C Br J Nurs; 2000 Dec 8-2001 Jan 10; 9(22):2281-90. PubMed ID: 12271194 [TBL] [Abstract][Full Text] [Related]
19. [Risks of infection caused by blood and blood products with reference to the so-called AIDS scandal]. Kretschmer V Infusionsther Transfusionsmed; 1993 Dec; 20(6):286-90. PubMed ID: 8142734 [No Abstract] [Full Text] [Related]
20. Hemoglobin-based blood substitutes and risk of myocardial infarction and death. Sarani B; Gracias V JAMA; 2008 Sep; 300(11):1297-8; author reply 1298-9. PubMed ID: 18799439 [No Abstract] [Full Text] [Related] [Next] [New Search]